Overview


According to FutureWise analysis the market for north america IVD in 2023 is US$ 51.72 billion, and is expected to reach US$ 66.08 billion by 2031 at a CAGR of 3.10%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of North America IVD Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the North America IVD Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott Laboratories
  • Johnson and Johnson
  • Siemens Healthineers
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche (Roche)
  • Beckman Coulter
  • BioMerieux S.A.
  • Ortho Clinical Dignostics, Inc
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Instruments
  • Kits
  • Reagents
  • Software

By Technology

  • Clinical Chemistry
  • Hematology
  • Immunoassay
  • Coagulation and Hemostasis
  • Molecular Diagnostics
  • Microbiology
  • Other IVD Technology

By Applications

  • Diabetes
  • Infectious Disease
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Disease
  • Drug Testing
  • HIV

By Region

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the North America IVD Market By Product, By Technology, By Applications and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— U.S.A, Canada, Mexico.
  • To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   North America IVD Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of North America IVD Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   North America IVD Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   North America IVD Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Instruments
        2. Kits
        3. Reagents
        4. Software

  • 8.   North America IVD Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Clinical Chemistry
        2. Hematology
        3. Immunoassay
        4. Coagulation and Hemostasis
        5. Molecular Diagnostics
        6. Microbiology
        7. Other IVD Technology

  • 9.   North America IVD Market, By Applications Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diabetes
        2. Infectious Disease
        3. Oncology/Cancer
        4. Cardiology
        5. Nephrology
        6. Autoimmune Disease
        7. Drug Testing
        8. HIV

  • 10.   North America IVD Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Market Share Analysis and Competitive Landscape
    •   1. North America Landscape - Key Players, Revenue and Presence
        2. North America Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. North America Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. North America Key Player - Growth Matrix

  • 12.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts)
    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Johnson and Johnson
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Siemens Healthineers
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Becton Dickinson and Company
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. F.Hoffmann-La Roche (Roche)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Beckman Coulter
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. BioMerieux S.A.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Ortho Clinical Dignostics, Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Bio-Rad Laboratories.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Danaher Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Sysmex Corporation
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Thermo Fisher Scientific Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Qiagen N.V.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 13.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 14.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients